HomeBUSINESS
BUSINESS

Nippon Chemiphar’s Antidepressant Candidate Selected for AMED’s CiCLE Grant Program
(Jan.12.2018)

Nippon Chemiphar said on January 11 that its investigational antidepressant/anti-anxiety agent NC-2800 has been selected for the Japan Agency for Medical Research and Development’s (AMED) Cyclic Innovation for Clinical Empowerment (CiCLE) grant program ...
(LOG IN FOR FULL STORY)

News Calendar